Bal Pharma Ltd.
BALPHARMA Share PricePharmaceuticals & Drugs
₹89.12
0.8 (0.8%)
As on September 8, 2025
Exchange Scrips: BSE524824NSEBALPHARMAISININE083D01012
Market Cap ₹ 142 Cr
P/E Ratio 19.05
Dividend Yield 0.13 %
Performance
Market performance
Open89.99
High90.1
Volumes21,965
Prev89.12
Low86.8
As on2025-09-08
Historical performance
1 Year High140.95
3 Year High157.98
5 Year High157.98
1 Year Low78.06
3 Year Low63.35
5 Year Low41.65
Fundamentals
Company Valuation
Market Cap (₹Cr)
142
Face Value (₹)
10
P/E Ratio
19.05
Dividend Yield
0.13 %
Investment Returns
1 Year
-33.3%
3 Years
-8.2%
5 Years
102.3%
10 Years
33.3%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 88.84 | Bullish |
| 10-DMA | 87.88 | Bullish |
| 20-DMA | 89.36 | Bearish |
| 50-DMA | 95.16 | Bearish |
| 100-DMA | 97.99 | Bearish |
| 200-DMA | 103.39 | Bearish |
Shareholding Pattern
| Field | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 |
|---|---|---|---|---|---|
| Promoters | 11 | 11 | 11 | 11 | 11 |
| Foreign Investors | 3 | 3 | 3 | 3 | 3 |
| Domestic Investors | 8 | 8 | 8 | 8 | 8 |
| Public Investors | 15815 | 15712 | 15656 | 15996 | 15003 |
| Government | --- | --- | --- | --- | --- |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 19.05.
- 3Y Stock Price CAGR of the stock is -3.5.
- The stock has a beta of 0.7.
- In the last financial year, the company had an EBITDA of ₹346 Million.
- The company generated revenue of ₹3392 Million in the previous financial year.
Bal Pharma Ltd.
89.120.8 (0.8%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 662897.9
No. of Shares: 7438 (Approx)
Performance:-33.7%
P/L: ₹-337102.1
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
Live video call With Our Agent